Cargando…
Targets and strategies for vaccine development against SARS-CoV-2
The SARS-CoV-2, previously called a novel coronavirus, that broke out in the Wuhan city of China caused a significant number of morbidity and mortality in the world. It is spreading at peak levels since the first case reported and the need for vaccines is in immense demand globally. Numerous treatme...
Autores principales: | Malik, Jonaid Ahmad, Mulla, Almas Hanif, Farooqi, Tahmeena, Pottoo, Faheem Hyder, Anwar, Sirajudheen, Rengasamy, Kannan R.R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Masson SAS.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843096/ https://www.ncbi.nlm.nih.gov/pubmed/33550049 http://dx.doi.org/10.1016/j.biopha.2021.111254 |
Ejemplares similares
-
An overview of SARS-COV-2 epidemiology, mutant variants, vaccines, and management strategies
por: Farooqi, Tahmeena, et al.
Publicado: (2021) -
The SARS-CoV-2 mutations versus vaccine effectiveness: New opportunities to new challenges
por: Malik, Jonaid Ahmad, et al.
Publicado: (2022) -
Association of
SARS-CoV-2 and Polypharmacy
with Gut–Lung Axis: From Pathogenesis to Treatment
por: Malik, Jonaid Ahmad, et al.
Publicado: (2022) -
SARS-CoV-2 vaccines: Clinical endpoints and psychological perspectives: A literature review
por: Malik, Jonaid Ahmad, et al.
Publicado: (2022) -
Micro-RNAs in the regulation of immune response against SARS CoV-2 and other viral infections
por: Abu-Izneid, Tareq, et al.
Publicado: (2020)